Level
Posted Date: Mar 5, 2025
- Investigator: Jennifer Cook
- Specialties:
- Type of Study: Drug
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF); LEVEL: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Criteria:
Null
Keywords:
Levosimendan For Pulm Htn Due To Hfpef
For More Information:
Harshada More
5135584739
morehp@ucmail.uc.edu